Renal & Urology Flashcards
(133 cards)
Define bladder cancer.
Cancer that forms in tissues of the bladder.
Most are transitional cell carcinomas - inner lining of bladder cells.
Explain the aetiology / risk factors of bladder cancer.
Risk factors:
- Tobacco exposure
- Exposure to chemical carcinogens
- Age >55 years
- Pelvic radiation
- Systemic chemotherapy
- Schistosoma infection
- Male sex
- Chronic bladder inflammation
- Positive FHx
- DM Type 2
Summarise the epidemiology of bladder cancer.
Ranks ninth in worldwide cancer incidence. Egypt, Western Europe, and North America have the highest incidence rates and Asian countries the lowest rates. More than 90% of new cases occur in people ≥55 years of age.
Over 90% of cancers of the urinary bladder are urothelial carcinoma (previously termed transitional cell carcinoma; UC). Non-muscle-invasive tumours are most common. Low-grade tumours are papillary and generally easy to visualise. High-grade tumours are often flat or in situ, and can be difficult to visualise. If muscle invasion occurs, transurethral resection is insufficient and radical cystoprostatectomy is usually advised.
Recognise the presenting symptoms of bladder cancer.
- Presence of risk factors
- Haematuria - gross or microscopic
- Dysuria
- Urinary frequency
Recognise the signs of bladder cancer on physical examination.
- Presence of risk factors
- Haematuria - gross or microscopic
- Dysuria
- Urinary frequency
Identify appropriate investigations for bladder cancer and interpret the results.
- Urinalysis - red blood cell casts and crenated red cells seen with glomerular bleeding, haematuria, pyuria
- Urine cytology - +ve in 90% of patients with carcinoma or high-grade tumours, <33% of patients with low-grade transitional cell
- Renal and bladder ultrasound - bladder tumours/ upper tract obstruction
- CT urogram - bladder tumours, upper urinary tract tumours, and/or obstruction
- Cystoscopy
- IV urogram - filing defects indicative of bladder tumours
- FBC - normal or mild anaemia
- Chemistry profile (AlkPhos) - normal or elevated AlkPhos (also give bone scan)
- CXR
- CT abdomen and pelvis - rule out stone disease, may reveal primary bladder cancer and/or metastatic disease
- MRI abdomen and pelvis
- MR urogram
- Bone scan - normal or hot spots indicative of bony deposits
- Urinary markers
Define prostate cancer.
A malignant tumour of glandular origin, situated in the prostate.
Explain the aetiology / risk factors of prostate cancer.
Risk factors:
- Age >50 years
- Black ethnicity
- North American or Northwest European descent
- Family history of prostate cancer
- High levels of dietary fat
Summarise the epidemiology of prostate cancer.
Prostate cancer is the second leading cause of cancer mortality in men in the US.
Uncommon in men aged under 50 years.
Recognise the presenting symptoms of prostate cancer.
- Presence of risk factors
- Nocturia
- Urinary frequency
- Urinary hesitancy
- Dysuria
- Haematuria
- Weight loss/anorexia
- Lethargy
- Bone pain
Recognise the signs of prostate cancer on physical examination.
- Elevated PSA
- Abnormal digital rectal exam
- Palpable lymph nodes
- Haematuria
Identify appropriate investigations for prostate cancer and interpret the results.
1st Line:
- Serum PSA - >4 micrograms / L
- Testosterone - baseline test for patients in whom androgen deprivation is considered
- LFTs - check for risk of hepatitis when giving androgen deprivation
- FBC - normal except for advanced metastatic disease
- Renal function - normal except for locally advanced disease causing obstruction
- Prostate biopsy - malignant cells detected (grade 1-5)
Consider:
- Bone scan
- Plain X-rays
- Pelvic CT scan
- Pelvic MRI / endorectal MRI
Define renal cell carcinoma.
A malignancy arising from renal parenchyma/ cortex, and accounts for about 85% of kidney cancers.
Explain the aetiology / risk factors of renal cell carcinoma.
Risk factors:
- Smoking
- Male sex
- Age over 55 years
- Residence in developed countries
- Black / American-Indian ethnicity
- Obesity
- Hypertension
- Positive family history of RCC
- History of hereditary syndrome
- History of acquired renal cystic disease
Weak risk factors:
- Asbestos/Cadmium
- Obstetric history / oestrogen exposure
- Pelvic radiation
Summarise the epidemiology of renal cell carcinoma.
RCC is the seventh most common form of neoplasm in the developed world. The surveillance, epidemiology, and end results (SEER) statistics report that in the US, about 74,000 new cases of kidney cancer were diagnosed in 2019, accounting for 4.2% of all cancer diagnoses (almost double the global average).
Recognise the presenting symptoms of renal cell carcinoma.
TRIAD = Flank pain, Haematuria, Palpable Abdominal Mass.
Can be asymptomatic - indicidental finding (>50%)
- Presence of risk factors
- Haematuria
- Flank pain
Non-specific systemic symptoms:
- Fever
- Weight loss
- Sweats
- Pallor
- Cachexia
- Myoneuropathy
Recognise the signs of renal cell carcinoma on physical examination.
- Flank tenderness
- Palpable abdominal mass
- Haematuria
Rare:
- Scrotal varicocele
Signs of hepatic dysfunction:
- Ascites
- Hepatomegaly
- Spider angiomata
Signs of IVC involvement:
- Lower limb oedema
Hereditary Syndromes:
- Dermatological manifestation
- Birt-Hogg-Dube - papules
- Hereditary leimyomatous - skin fibromas
Von Hippel Lindau:
- Vision loss
- Retinal angiomatosis detected on fundoscopy
Identify appropriate investigations for renal cell carcinoma and interpret the results.
BLOODS
- FBC - paraneoplastic syndrome (reduced Hb or elevated RBC) symptoms such as anaemia of chronic disease, erythrocytosis
- LDH - >1.5 upper limit
- Corrected calcium - >2.5mmol/L (>10mg/dL)
- LFTs - metastatic disease / paraneoplastic syndrome= abnormal
Transaminitis (elevated liver transaminases, aspartate aminotransferase/alanine aminotransferase) and/or poor liver function may be indicative of metastatic lesions.
In the absence of liver metastases, cholestasis (elevated bilirubin, alk phos, gamma-GT), with concomitant elevated prothrombin time, thrombocytosis, and hepatosplenomegaly, is a paraneoplastic presentation of RCC known as Stauffer syndrome.
- Coagulation - elevated PT in paraneoplastic syndrome
In the absence of liver metastases, cholestasis (elevated bilirubin, alk phos, gamma-GT), with concomitant elevated prothrombin time (PT), thrombocytosis, and hepatosplenomegaly, is a paraneoplastic presentation of RCC known as Stauffer syndrome
- Creatinine - elevated with reduced creatinine clearance indicating chronic renal insufficiency either preceding or due to RCC (know baseline function)
URINALYSIS
- Haematuria
- Proteinuria - seen in CKD and HTN which are risk factors for RCC
IMAGING
- Abdominal / pelvic US Scan - cyst / mass, lymphadenopathy
- CT CAP - renal mass, lymphadenopathy, bone or visceral metastases
- MRI CAP - renal mass, lymphadenopathy, bone or visceral metastases
- Bone scan - uptake in bone site consistent with metastases (if bone pain or elevated AlkPhos)
Define testicular cancer.
Cancer that forms in tissues of one or both testicles. Testicular cancer is most common in young or middle-aged men. Most testicular cancers begin in germ cells (cells that make sperm) and are called testicular germ cell tumors.
Explain the aetiology / risk factors of testicular cancer.
Risk factors:
- Cryptorchidism
- Gonadal dysgenesis
- Family history of testicular cancer
- Personal history of testicular cancer
- Testicular atrophy
- White ethnicity
- HIV infection
- Chemical carcinogens and low sperm count
- Rural residence
- Higher socioeconomic status
- Inguinal hernia
- Genetic abnormality
Summarise the epidemiology of testicular cancer.
The most common malignancy in young adult men (20 to 34 years of age), and highly curable when diagnosed early.
Recognise the presenting symptoms of testicular cancer.
- Presence of risk factors
- Age 20-34 years
- Testicular mass - 55% on right side, 2% bilateral, 85% painless, 10% acute pain
- Extratesticular manifestation - e.g. bone pain, extremity swelling (venous occlusion), supraclavicular lymph nodes, hyperthyroidism, gynaecomastia
Recognise the signs of testicular cancer on physical examination.
- Presence of risk factors
- Age 20-34 years
- Testicular mass - 55% on right side, 2% bilateral, 85% painless, 10% acute pain
- Extratesticular manifestation - e.g. bone pain, extremity swelling (venous occlusion), supraclavicular lymph nodes, hyperthyroidism, gynaecomastia
Identify appropriate investigations for testicular cancer and interpret the results.
- Ultrasound with colour Doppler of testis - testicular mass
- CXR - mediastinal and lung mass suggestive of metastasis
- CT Scan (AP) - enlarged retroperitoneal lymph nodes
- Serum beta-hCG - >0.7 IU/L - elevated in all choriocarcinomas, 5-10% of seminomas
- Serum AFP - >25microgram / L - elevated by embryonal carcinoma, yolk sac tumours, combined tumours but NOT choriocarcinomas and seminomas
- Serum LDH - only elevated marker in 10% of non-seminomas, elevated in 50% of all cases
- Histological examination of testicular mass post-rochiectomy
- Serum placenta AlkPhos - elevated in 40% patients with advanced disease
- Serum gamma-GT - >85 U/L in 1/3 cases of seminoma
- MRI AP - staging tool
- CT Chest - show metastatic lesions